{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T10:54:01Z","timestamp":1781520841416,"version":"3.54.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,15]]},"DOI":"10.7759\/cureus.110874","type":"journal-article","created":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T10:14:10Z","timestamp":1781518450000},"source":"Crossref","is-referenced-by-count":0,"title":["Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Versus Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists Following Orthopedic Shoulder Surgery: A Comparative Analysis"],"prefix":"10.7759","author":[{"given":"Ronak J","family":"Mahatme","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shawn A","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anish","family":"Gangavaram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nishanth","family":"Muthusamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L","family":"Bernholt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian M","family":"Grawe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)01301-6","article-title":"Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021","volume":"402","year":"2023","unstructured":"Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050. a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2023, 402:203-34. 10.1016\/S0140-6736(23)01301-6","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.2991\/jegh.k.191028.001","article-title":"Epidemiology of type 2 diabetes - global burden of disease and forecasted trends","volume":"10","author":"Khan MA","year":"2020","unstructured":"Khan MA, Hashim MJ, King JK, Govender RD, Mustafa H, Al Kaabi J. Epidemiology of type 2 diabetes - global burden of disease and forecasted trends. J Epidemiol Glob Health. 2020, 10:107-11. 10.2991\/jegh.k.191028.001","journal-title":"J Epidemiol Glob Health"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijsu.2022.106789","article-title":"The impact of diabetes on postoperative outcomes following spine surgery: a meta-analysis of 40 cohort studies with 2.9 million participants","volume":"104","author":"Luo M","year":"2022","unstructured":"Luo M, Cao Q, Wang D, et al.. The impact of diabetes on postoperative outcomes following spine surgery: a meta-analysis of 40 cohort studies with 2.9 million participants. Int J Surg. 2022, 104:106789. 10.1016\/j.ijsu.2022.106789","journal-title":"Int J Surg"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1677542","article-title":"Postoperative complications and impact of diabetes mellitus severity on revision total knee arthroplasty","volume":"33","author":"Gu A","year":"2020","unstructured":"Gu A, Wei C, Robinson HN, Sobrio SA, Liu J, Sculco TP, Sculco PK. Postoperative complications and impact of diabetes mellitus severity on revision total knee arthroplasty. J Knee Surg. 2020, 33:228-34. 10.1055\/s-0038-1677542","journal-title":"J Knee Surg"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/ans.15878","article-title":"Do patients with diabetes have an increased risk of impaired fracture healing? A systematic review and meta-analysis","volume":"90","author":"Ding ZC","year":"2020","unstructured":"Ding ZC, Zeng WN, Rong X, Liang ZM, Zhou ZK. Do patients with diabetes have an increased risk of impaired fracture healing? A systematic review and meta-analysis. ANZ J Surg. 2020, 90:1259-64. 10.1111\/ans.15878","journal-title":"ANZ J Surg"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.12968\/jowc.2022.31.10.882","article-title":"Impaired wound healing in diabetes","volume":"31","author":"Swoboda L","year":"2022","unstructured":"Swoboda L, Held J. Impaired wound healing in diabetes. J Wound Care. 2022, 31:882-5. 10.12968\/jowc.2022.31.10.882","journal-title":"J Wound Care"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jse.2014.01.046","article-title":"Diabetes as a risk factor for poorer early postoperative outcomes after shoulder arthroplasty","volume":"23","author":"Ponce BA","year":"2014","unstructured":"Ponce BA, Menendez ME, Oladeji LO, Soldado F. Diabetes as a risk factor for poorer early postoperative outcomes after shoulder arthroplasty. J Shoulder Elbow Surg. 2014, 23:671-8. 10.1016\/j.jse.2014.01.046","journal-title":"J Shoulder Elbow Surg"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jse.2017.05.027","article-title":"The impact of insulin dependence on short-term postoperative complications in diabetic patients undergoing total shoulder arthroplasty","volume":"26","author":"Fu MC","year":"2017","unstructured":"Fu MC, Boddapati V, Dines DM, Warren RF, Dines JS, Gulotta LV. The impact of insulin dependence on short-term postoperative complications in diabetic patients undergoing total shoulder arthroplasty. J Shoulder Elbow Surg. 2017, 26:2091-6. 10.1016\/j.jse.2017.05.027","journal-title":"J Shoulder Elbow Surg"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1080\/00913847.2020.1811617","article-title":"Diabetes is an independent risk factor for infection after non-arthroplasty shoulder surgery: a national database study","volume":"49","author":"Bitzer A","year":"2021","unstructured":"Bitzer A, Mikula JD, Aziz KT, Best MJ, Nayar SK, Srikumaran U. Diabetes is an independent risk factor for infection after non-arthroplasty shoulder surgery: a national database study. Phys Sportsmed. 2021, 49:229-35. 10.1080\/00913847.2020.1811617","journal-title":"Phys Sportsmed"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1177\/2325967120961406","article-title":"Patients with diabetes mellitus have a higher risk of tendon retear after arthroscopic rotator cuff repair: a meta-analysis","volume":"8","author":"Hong CK","year":"2020","unstructured":"Hong CK, Chang CJ, Kuan FC, Hsu KL, Chen Y, Chiang CH, Su WR. Patients with diabetes mellitus have a higher risk of tendon retear after arthroscopic rotator cuff repair: a meta-analysis. Orthop J Sports Med. 2020, 8:2325967120961406. 10.1177\/2325967120961406","journal-title":"Orthop J Sports Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1177\/1758573219831691","article-title":"Diabetic patients are almost twice as likely to experience complications from arthroscopic rotator cuff repair","volume":"12","author":"Borton Z","year":"2020","unstructured":"Borton Z, Shivji F, Simeen S, et al.. Diabetic patients are almost twice as likely to experience complications from arthroscopic rotator cuff repair. Shoulder Elbow. 2020, 12:109-13. 10.1177\/1758573219831691","journal-title":"Shoulder Elbow"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.2106\/JBJS.RVW.24.00181","article-title":"Perioperative management, complications, and outcomes of shoulder arthroplasty in patients with diabetes mellitus","volume":"13","author":"Viqueira M","year":"2025","unstructured":"Viqueira M, Stadler RD, Sudah SY, et al.. Perioperative management, complications, and outcomes of shoulder arthroplasty in patients with diabetes mellitus. JBJS Rev. 2025, 13:e24.00181. 10.2106\/JBJS.RVW.24.00181","journal-title":"JBJS Rev"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jos.2024.01.003","article-title":"Perioperative glycemic control reduces the risk of retear in diabetic patients following arthroscopic rotator cuff repair: a meta-analysis","volume":"30","author":"Liang J","year":"2025","unstructured":"Liang J, Liang Q, Wang X, Yun X. Perioperative glycemic control reduces the risk of retear in diabetic patients following arthroscopic rotator cuff repair: a meta-analysis. J Orthop Sci. 2025, 30:78-84. 10.1016\/j.jos.2024.01.003","journal-title":"J Orthop Sci"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.5435\/JAAOS-D-16-00784","article-title":"Association of perioperative glycemic control with deep postoperative infection after shoulder arthroplasty in patients with diabetes","volume":"26","author":"Cancienne JM","year":"2018","unstructured":"Cancienne JM, Brockmeier SF, Werner BC. Association of perioperative glycemic control with deep postoperative infection after shoulder arthroplasty in patients with diabetes. J Am Acad Orthop Surg. 2018, 26:e238-45. 10.5435\/JAAOS-D-16-00784","journal-title":"J Am Acad Orthop Surg"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.00178","article-title":"GLP-1 analogs and DPP-4 inhibitors in type 2 diabetes therapy: review of head-to-head clinical trials","volume":"11","author":"Gilbert MP","year":"2020","unstructured":"Gilbert MP, Pratley RE. GLP-1 analogs and DPP-4 inhibitors in type 2 diabetes therapy: review of head-to-head clinical trials. Front Endocrinol (Lausanne). 2020, 11:178. 10.3389\/fendo.2020.00178","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.12361","article-title":"GLP-1 receptor agonists vs. DPP-4 inhibitors for type 2 diabetes: is one approach more successful or preferable than the other?","volume":"68","author":"Brunton S","year":"2014","unstructured":"Brunton S. GLP-1 receptor agonists vs. DPP-4 inhibitors for type 2 diabetes: is one approach more successful or preferable than the other?. Int J Clin Pract. 2014, 68:557-67. 10.1111\/ijcp.12361","journal-title":"Int J Clin Pract"},{"key":"ref17","unstructured":"TriNetX Research Network. Accessed. August 4, 2025: https:\/\/trinetx.com\/."},{"key":"ref18","unstructured":"Current Procedural Terminology (CPT). Accessed. August 4, 2025: https:\/\/www.ama-assn.org\/practice-management\/cpt."},{"key":"ref19","unstructured":"ICD-10-CM. Accessed. August 4, 2025:  https:\/\/www.cdc.gov\/nchs\/icd\/icd-10-cm\/index.html."},{"key":"ref20","unstructured":"RxNorm. Accessed. August 4, 2025: https:\/\/www.nlm.nih.gov\/research\/umls\/rxnorm\/index.html."},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-1241.2006.01178.x","article-title":"DPP-4 inhibitors and their potential role in the management of type 2 diabetes","volume":"60","author":"Barnett A","year":"2006","unstructured":"Barnett A. DPP-4 inhibitors and their potential role in the management of type 2 diabetes. Int J Clin Pract. 2006, 60:1454-70. 10.1111\/j.1742-1241.2006.01178.x","journal-title":"Int J Clin Pract"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.2337\/dc11-s229","article-title":"DPP-4 inhibitors: impact on glycemic control and cardiovascular risk factors","volume":"34 Suppl 2","author":"Dicker D","year":"2011","unstructured":"Dicker D. DPP-4 inhibitors: impact on glycemic control and cardiovascular risk factors. Diabetes Care. 2011, 34 Suppl 2:S276-8. 10.2337\/dc11-s229","journal-title":"Diabetes Care"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jse.2023.06.034","article-title":"Elevated HbA(1c) is not associated with reoperation following arthroscopic rotator cuff repair in patients with diabetes mellitus","volume":"33","author":"Khan AZ","year":"2024","unstructured":"Khan AZ, Vaughan A, Mandava NK, Wickes C, Ramsey ML, Namdari S. Elevated HbA(1c) is not associated with reoperation following arthroscopic rotator cuff repair in patients with diabetes mellitus. J Shoulder Elbow Surg. 2024, 33:247-54. 10.1016\/j.jse.2023.06.034","journal-title":"J Shoulder Elbow Surg"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-025-02468-5","article-title":"Effect of GLP-1 receptor agonists on bone mineral density, bone metabolism markers, and fracture risk in type 2 diabetes: a systematic review and meta-analysis","volume":"62","author":"Tan Y","year":"2025","unstructured":"Tan Y, Liu S, Tang Q. Effect of GLP-1 receptor agonists on bone mineral density, bone metabolism markers, and fracture risk in type 2 diabetes: a systematic review and meta-analysis. Acta Diabetol. 2025, 62:589-606. 10.1007\/s00592-025-02468-5","journal-title":"Acta Diabetol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocd.2023.101455","article-title":"Meta-analysis on the association between DPP-4 inhibitors and bone mineral density and osteoporosis","volume":"27","author":"Huang L","year":"2024","unstructured":"Huang L, Zhong W, Liang X, Wang H, Fu SE, Luo Z. Meta-analysis on the association between DPP-4 inhibitors and bone mineral density and osteoporosis. J Clin Densitom. 2024, 27:101455. 10.1016\/j.jocd.2023.101455","journal-title":"J Clin Densitom"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0287697","article-title":"Postoperative opioid prescribing patients with diabetes: opportunities for personalized pain management","volume":"18","author":"Zammit A","year":"2023","unstructured":"Zammit A, Coquet J, Hah J, et al.. Postoperative opioid prescribing patients with diabetes: opportunities for personalized pain management. PLoS One. 2023, 18:e0287697. 10.1371\/journal.pone.0287697","journal-title":"PLoS One"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0141921","article-title":"Exenatide facilitates recovery from oxaliplatin-induced peripheral neuropathy in rats","volume":"10","author":"Fujita S","year":"2015","unstructured":"Fujita S, Ushio S, Ozawa N, Masuguchi K, Kawashiri T, Oishi R, Egashira N. Exenatide facilitates recovery from oxaliplatin-induced peripheral neuropathy in rats. PLoS One. 2015, 10:e0141921. 10.1371\/journal.pone.0141921","journal-title":"PLoS One"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-024-01821-3","article-title":"Glucagon-like peptide-1 (GLP-1) receptor agonists for headache and pain disorders: a systematic review","volume":"25","author":"Halloum W","year":"2024","unstructured":"Halloum W, Dughem YA, Beier D, Pellesi L. Glucagon-like peptide-1 (GLP-1) receptor agonists for headache and pain disorders: a systematic review. J Headache Pain. 2024, 25:112. 10.1186\/s10194-024-01821-3","journal-title":"J Headache Pain"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.3390\/biom15050622","article-title":"Therapeutic effects of GLP-1 receptor agonists and DPP-4 inhibitors in neuropathic pain: mechanisms and clinical implications","volume":"15","author":"Kuthati Y","year":"2025","unstructured":"Kuthati Y, Davuluri VN, Wong CS. Therapeutic effects of GLP-1 receptor agonists and DPP-4 inhibitors in neuropathic pain: mechanisms and clinical implications. Biomolecules. 2025, 15:622. 10.3390\/biom15050622","journal-title":"Biomolecules"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.170671","article-title":"The glucagon-like peptide-1 (GLP-1) analogue semaglutide reduces alcohol drinking and modulates central GABA neurotransmission","volume":"8","author":"Chuong V","year":"2023","unstructured":"Chuong V, Farokhnia M, Khom S, et al.. The glucagon-like peptide-1 (GLP-1) analogue semaglutide reduces alcohol drinking and modulates central GABA neurotransmission. JCI Insight. 2023, 8:170671. 10.1172\/jci.insight.170671","journal-title":"JCI Insight"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.2147\/DMSO.S375559","article-title":"The relationship between the blood-brain-barrier and the central effects of glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors","volume":"15","author":"Dong M","year":"2022","unstructured":"Dong M, Wen S, Zhou L. The relationship between the blood-brain-barrier and the central effects of glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors. Diabetes Metab Syndr Obes. 2022, 15:2583-97. 10.2147\/DMSO.S375559","journal-title":"Diabetes Metab Syndr Obes"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1152\/jn.00228.2024","article-title":"Impact of glucagon-like peptide-1 receptor agonists on axonal function in diabetic peripheral neuropathy","volume":"133","author":"Dhanapalaratnam R","year":"2025","unstructured":"Dhanapalaratnam R, Issar T, Poynten AM, Milner KL, Kwai NC, Krishnan AV. Impact of glucagon-like peptide-1 receptor agonists on axonal function in diabetic peripheral neuropathy. J Neurophysiol. 2025, 133:14-21. 10.1152\/jn.00228.2024","journal-title":"J Neurophysiol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/501060-dipeptidyl-peptidase-4-dpp-4-inhibitors-versus-glucagon-like-peptide-1-glp-1-receptor-agonists-following-orthopedic-shoulder-surgery-a-comparative-analysis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T10:14:13Z","timestamp":1781518453000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/501060-dipeptidyl-peptidase-4-dpp-4-inhibitors-versus-glucagon-like-peptide-1-glp-1-receptor-agonists-following-orthopedic-shoulder-surgery-a-comparative-analysis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,15]]},"references-count":32,"URL":"https:\/\/doi.org\/10.7759\/cureus.110874","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6,15]]}}}